German MDx Firm Mainz Biomed Raises $10M in IPO, Begins Trading on Nasdaq - NewsBreak

NEW YORK – Mainz Biomed, a German molecular diagnostics company developing tests for the early detection of cancer, said on Monday that its shares have started trading on the Nasdaq Capital Market under the ticker symbol MYNZ. The company, whose lead product is a colorectal cancer diagnostic called ColoAlert,...